C34H36FN7O9S — CID 176723389
2-[4-[1-(2,6-dioxopiperidin-3-yl)-3-ethyl-2-oxobenzimidazol-5-yl]piperidin-1-yl]-N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-3-hydroxypropanamide (PubChem CID 176723389) has the molecular formula C34H36FN7O9S and a molecular weight of 737.77 g/mol. Its IUPAC name is 2-[4-[1-(2,6-dioxopiperidin-3-yl)-3-ethyl-2-oxobenzimidazol-5-yl]piperidin-1-yl]-N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-3-hydroxypropanamide.
| Compound Name | 2-[4-[1-(2,6-dioxopiperidin-3-yl)-3-ethyl-2-oxobenzimidazol-5-yl]piperidin-1-yl]-N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-3-hydroxypropanamide |
|---|---|
| PubChem CID | 176723389 |
| Molecular Formula | C34H36FN7O9S |
| Molecular Weight | 737.77 g/mol |
| Exact Mass | 737.23 |
| IUPAC Name | 2-[4-[1-(2,6-dioxopiperidin-3-yl)-3-ethyl-2-oxobenzimidazol-5-yl]piperidin-1-yl]-N-[5-fluoro-7-hydroxy-6-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]-3-hydroxypropanamide |
| SMILES | CCn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(C3CCN(C(CO)C(=O)Nc4ccc5c(F)c(N6CC(=O)NS6(=O)=O)c(O)cc5c4)CC3)cc21 |
| InChI | InChI=1S/C34H36FN7O9S/c1-2-40-25-14-19(3-6-23(25)42(34(40)49)24-7-8-28(45)37-32(24)47)18-9-11-39(12-10-18)26(17-43)33(48)36-21-4-5-22-20(13-21)15-27(44)31(30(22)35)41-16-29(46)38-52(41,50)51/h3-6,13-15,18,24,26,43-44H,2,7-12,16-17H2,1H3,(H,36,48)(H,38,46)(H,37,45,47) |
| InChIKey | ARVDCCDOKUPCCX-UHFFFAOYSA-N |
| XLogP | 1.16 |
| TPSA | 212.38 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 52 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 737.77 |
| LogP ≤ 5 | 1.16 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|